The email sent will contain a link to this article, the article title, and an article excerpt (if available). For security reasons, your IP address will also be included in the sent email.
November 11, 2011
By Leslie Carol Botha, Vice-President Public Relations
Gardasil Contaminated with HPV rDNA
In September of this year, SANE Vax Inc. broke the news that 100% of the Gardasil vials tested proved to be contaminated with a recombinant HPV DNA attached to aluminum. The nonprofit organization contracted with a private lab to run the tests at request of informed physician and medical consumers concerned about HPV vaccine safety and efficacy. The laboratory informed SANE Vax Inc. that one hundred percent of the thirteen (13) samples of Gardasil™ taken from lots #1437Z, #1511Z, #0553AA, #NL35360, #NP23400, #NN33070, #NL01490, #NM25110, #NL39620, #NK16180, #NK00140, #NM08120 and #NL13560, currently being marketed in the U.S.A., Australia, New Zealand, Spain, France, and Poland were found to be positive for HPV rDNA.
In the past month global government health agencies went from demanding that vaccine contamination be investigated – to accepting a universal statement possibly written by Merck – that the agencies were well aware that the ‘presence of DNA fragments was to be expected and did not pose a safety risk. 1. And life went on as usual.
On October 25, 2011, an advisory panel to the CDC, who actually receives a ‘kick-back’ on Gardasil sales recommended that the vaccine be administered to boys ages 9 to 26 – creating a whole new market for sales and profits. The recommendation, which falls short of a mandate, means Merck’s Gardasil vaccine could be added to vaccination schedules in pediatricians’ offices across the country.2
Return to Article